A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
A video of a Beatles fan singing to his dying newborn son has now been seen fifteen million times online.
Becoming windy, especially in the west, as rain spreads northeastwards.
Wigan Athletic have received another blow after drinks company iPro Sport ended their sponsorship deal with the Championship club.